1036 Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice.
http://www.nature.com/nature/journal/v544/n7650/full/nature22038.html
1035 Antisense oligonucleotide therapy for spinocerebellar ataxia type 2.
http://www.nature.com/nature/journal/v544/n7650/full/nature22044.html
1034 Myt1l safeguards neuronal identity by actively repressing many non-neuronal fates.
http://www.nature.com/nature/journal/v544/n7649/full/nature21722.html
1033 Transfer of pathogenic and nonpathogenic cytosolic proteins between spinal cord motor neurons in vivo in chimeric mice.
http://www.pnas.org/content/114/15/E3139.abstract
1032 Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s disease.
http://www.pnas.org/content/114/15/3999
1031 Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer’s disease.
http://www.nature.com/articles/ncomms14727
1030 Low-dose penicillin in early life induces long-term changes in murine gut microbiota, brain cytokines and behavior.
http://www.nature.com/articles/ncomms15062
1029 Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a.
http://www.pnas.org/content/114/14/3750.abstract
1028 The representation of contextual fear memories evolves over time in the hippocampus, amygdala, and prefrontal cortex.
http://science.sciencemag.org/content/356/6333/73
1027 Ancient evolutionary origin of vertebrate enteric neurons from trunk-derived neural crest.
http://www.nature.com/nature/journal/v544/n7648/full/nature21679.html
|
